Cellective BioTherapy
-
2015 April 01
Company Description
Focused on developing novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and immunodeficiency.
Cellective BioTherapy is a biotechnology company that focuses on research and development of B cell-based cellular therapies for immunomodulation, immunodeficiency, and autoimmunity. It researches about treatment for cancers, diabetes, asthma, and congenital and acquired immunodeficiency, and vaccine development. Cellective BioTherapy was founded by Dr. Thomas F. Tedder in April 2015. It is based in Raleigh, North Carolina.
-
Manufacturer:
Information Technology -
Formed:
April 1, 2015 -
Founders:
Dr. Thomas F. Tedder -
Company Website:
-
Company E-mail:
-
Company Address:
6 Davis Drive, Research Triangle ParkRaleigh, NCUnited States -
CEO:
- Dr. Thomas F. Tedder
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits